ArticleBJPsych open2018
The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis.
Article in BJPsych open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.
- Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis.Translational psychiatry · 2021Pooled it
- The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.The lancet. Psychiatry · 2019Pooled it
- Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis.Biological psychiatry · 2021Trial
- Psychiatric symptoms as clinical warning signals of adult anti-LGI-1 encephalitis: an observational cohort study.BMC psychiatry · 2026Observational
- Prevalence of anti-NMDA receptor antibodies among adult patients presenting with first-episode psychosis in Hong Kong.Schizophrenia (Heidelberg, Germany) · 2026Article
- Clinical Criteria to Guide Antineuronal Antibody Testing for People With Early and Persistent Psychosis Attending Mental Health Services.Biological psychiatry global open science · 2026Article
- A Case Series of Young People Receiving Adjunctive Immunotherapy for Neuroimmune-Mediated Major Mood or Psychotic Syndromes.Biological psychiatry global open science · 2025Article
- Neural Antibodies in First-episode Psychosis Patients with Warning Signs for Autoimmune Encephalitis.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024Article
- Neurobiology of Psychosis and Schizophrenia 2021: Nottingham Meeting.Schizophrenia bulletin · 2022Article
- Autoantibody profiles associated with clinical features in psychotic disorders.Translational psychiatry · 2021Article
- Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.Frontiers in psychiatry · 2021Article
- An Australian State-Based Cohort Study of Autoimmune Encephalitis Cases Detailing Clinical Presentation, Investigation Results, and Response to Therapy.Frontiers in neurology · 2021Article
- Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach.Brain, behavior, & immunity - health · 2020Article
- Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety.Translational psychiatry · 2020Article
- Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States.The Journal of clinical psychiatry · 2020Article
- Article
- Testing forThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2020Article
- A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders.Scientific reports · 2019Article
- Autoimmune encephalitis in the elderly: who to test and what to test for.Evidence-based mental health · 2019Review
- Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis.BJPsych open · 2018Article
Corrections and comments
- Commented on by
Authors and funding
14 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntineuronal antibodies are associated with psychosis, although their clinical significance in first episode of psychosis (FEP) is undetermined.
aimsTo examine all patients admitted for treatment of FEP for antineuronal antibodies and describe clinical presentations and treatment outcomes in those who were antibody positive.
methodIndividuals admitted for FEP to six mental health units in Queensland, Australia, were prospectively tested for serum antineuronal antibodies. Antibody-positive patients were referred for neurological and immunological assessment and therapy.
resultsOf 113 consenting participants, six had antineuronal antibodies (anti-
conclusionsA small subgroup of patients admitted to hospital with FEP have antineuronal antibodies detectable in serum and are responsive to immunotherapy. Early diagnosis and treatment is critical to optimise recovery. DECLARATION OF INTEREST: None.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.